Drug Profile
Nicotine - Celltech Group
Alternative Names: Nicotine tartrateLatest Information Update: 08 Jan 2022
Price :
$50
*
At a glance
- Originator Mayo Clinic
- Developer Celltech Group; Mayo Clinic
- Class Alkaloids; Analgesics; Drug withdrawal therapies; Nicotine replacement therapy; Pyridines; Small molecules
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ulcerative colitis
Most Recent Events
- 29 Mar 2000 Discontinued-Clinical for Ulcerative colitis in USA (PO)
- 29 Mar 2000 Discontinued-II for Ulcerative colitis in USA (Rectal)
- 02 Feb 2000 Medeva has been merged into Celltech Chiroscience, which is now called Celltech Group